Lab901 has announced an extension of the user base for its protein Screentape platform for rapid, automated SDS-PAGE.
The company has completed shipments of Screentape systems to ESBATech, Crucell, Symphogen, Bayer Healthcare and multiple systems to Novartis Basel.
Lab901 recently expanded the application base for protein Screentape to 'at-line' monitoring of monoclonal antibody production and presented at the Peptalk meeting in San Diego.
The protein Screentape systems offer fully automated SDS-PAGE and analysis in less than one minute per sample.
Users are provided with a gel image, electropherogram and information such as molecular weight, percentage purity and quantity in a fraction of the time needed when using traditional pre-cast gel methods, according to Lab901.
Unused lanes on Screentape can be used for subsequent experiments.
